Forum
Date: December 3, 2019
Location: Regenstrief Institute, 1101 W. 10th St., Indianapolis, IN 46202

REEF – Regenstrief Entrepreneurial Ecosystem Forum

Putting the I in AI: How healthcare innovators are using data to move from ideas to implementation

This session will feature companies accomplishing meaningful outcomes using data and AI, including Medial Earlysign (Israel), Roche Diagnostics (Indianapolis), and Ventech Solutions (Columbus, OH). The panel will be moderated by Dr. Shaun Grannis, a global thought leader in health and data, who recently presented in Washington DC on the FDA’s real-world evidence (RWE) initiative and works closely with policy makers to advance national identity management strategy.

Please join Regenstrief, panel guests and other entrepreneurs for our last REEF event of 2019. Lunch will be served. An interactive expo session after the panel will allow for attendees to network with those working at the intersection of health and data.

We are limited to 100 participants, so register early!

LEARN MORE

Related News

Kathleen Unroe, M.D.

Barriers to Discharge for Nursing Home Residents With Serious Mental Illness

Published in the JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Kathleen T. Unroe,

Validation of a MIND diet screener in older adults

Published in Alzheimer’s & Dementia Journal. Here is a link to the article. Regenstrief Institute author: Daniel O. Clark,

Fairbanks, Lilly, Regenstrief and Indiana employers collaborate to study obesity medications’ impact

Fairbanks, Lilly, Regenstrief and Indiana employers collaborate to study obesity medications’ impact

INDIANAPOLIS — Researchers from the Fairbanks School of Public Health at Indiana University Indianapolis have launched a first-of-its-kind study

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults

Music for the brain: Study tests the effect of slow-tempo relaxing music to address delirium in critically ill older adults

Findings support longer-duration or targeted approaches A multi-center randomized controlled trial with critically ill adults aged 50 years and